Additionally, several studies indicated that the degradation of HDAC2 is one of the anticancer actions of VPA (28, 39) and that knockdown of HDAC2 enhances the sensitivity of GBM cancer cells to TMZ (40). The gene discussed is HDAC2; the disease is cancer.